{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-013049","form_type":"8-K","ticker":"NVCT","cik":"0001875558","company_name":"Nuvectis Pharma, Inc.","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.646252+00:00","generated_at":"2026-05-16T03:23:01.584039+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nuvectis Pharma reports FY2025 net loss $26.4M; cash $31.6M; NXP900 program advancing","bullets":["Net loss $26.4M for FY2025 vs $19.0M in FY2024; includes $6.0M stock-based comp and $2.4M milestone license fees.","Cash and equivalents $31.6M at Dec 31, 2025, up from $18.5M; funded by public offering and ATM facility.","R&D expenses $18.2M (up from $12.9M), G&A $9.4M (up from $6.9M); finance income $1.1M.","NXP900 Phase 1b monotherapy enrolling; combination with osimertinib (EGFR-mutated NSCLC) enrolling; lorlatinib combo pending.","CEO expects current cash to fund operations through multiple Phase 1b milestones into H2 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-013049","json":"https://secwatch.observer/filing/0001104659-26-013049.json","markdown":"https://secwatch.observer/filing/0001104659-26-013049.md","text":"https://secwatch.observer/filing/0001104659-26-013049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013049/0001104659-26-013049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013049/tm265090d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:23:01.584039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}